The groundbreaking rise of Viagra has firmly established as a benchmark of pharmaceutical success, however its future within the broader market now triggers questions about future yields . Alternative versions are undercutting patent protection , leading to concerns that betting on companies significantly dependent to Viagra's previous standing cou